I thought it was a bit odd for James to promise data after just one group, especially since the trials start with the lowest dose. That's alot of paperwork for all involved and alot of pauses in trading, not to mention isolated data, if we get results after every group. I suspect an interim readout may be a little while away yet. But I may be wrong.
Ann: Update on Phase I/II Clinical Trial for Burn Wound Infection, page-99
Add RCE (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
57.0¢ |
Change
-0.010(1.72%) |
Mkt cap ! $116.2M | |||
| Open | High | Low | Value | Volume |
| 58.0¢ | 59.5¢ | 57.0¢ | $7.252K | 12.64K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 34780 | 57.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 59.5¢ | 60000 | 1 |
View Market Depth
| Last trade - 16.10pm 29/05/2024 (20 minute delay) ? |
|
|||||
|
Last
58.5¢ |
Change
-0.010 ( 0.85 %) |
||||
| Open | High | Low | Volume | ||
| 57.0¢ | 58.5¢ | 57.0¢ | 4583 | ||
| Last updated 15.27pm 29/05/2024 ? | |||||
| RCE (ASX) Chart |